Option Care Health, Inc.
OPCHNasdaqCIK 1014739HealthcareFiscal year ends Dec 31
Reports and events: 426 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0608:22 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-113904 |
| 2026-07-2907:26 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001014739-26-000023 |
| 2026-07-2906:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-26-000021 |
| 2026-05-2216:00 ET | 8-K | 5.07 Shareholder vote results | 0001014739-26-000017 |
| 2026-05-1207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-058979 |
| 2026-05-0516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001014739-26-000014 |
| 2026-04-3016:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001014739-26-000011 |
| 2026-04-3007:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-052099 |
| 2026-04-0816:15 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001140361-26-013825 |
| 2026-04-0216:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-039171 |
| 2026-02-2416:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001014739-26-000008 |
| 2026-02-2406:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-26-000005 |
| 2026-01-1216:31 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002887 |
| 2025-10-3016:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001014739-25-000046 |
| 2025-10-3006:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-25-000043 |
| 2025-09-2516:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-093337 |
| 2025-08-2016:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-080912 |
| 2025-07-3016:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001014739-25-000037 |
| 2025-07-3006:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-25-000034 |
| 2025-05-1616:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001014739-25-000028 |
| 2025-04-2916:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001014739-25-000022 |
| 2025-04-2906:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-25-000018 |
| 2025-04-0216:06 ET | DEF 14A | Proxy statementPeriod 2025-05-14 | 0001140361-25-011852 |
| 2025-02-2616:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001014739-25-000012 |
| 2025-02-2606:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-25-000008 |
| 2025-01-1307:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-002847 |
| 2024-10-3016:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001014739-24-000052 |
| 2024-10-3006:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-24-000048 |
| 2024-09-0616:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws | 0001014739-24-000041 |
| 2024-07-3116:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001014739-24-000035 |
| 2024-07-3106:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-24-000032 |
| 2024-05-1716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001014739-24-000025 |
| 2024-05-1016:07 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-059895 |
| 2024-04-2316:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001014739-24-000022 |
| 2024-04-2306:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-24-000019 |
| 2024-04-0316:06 ET | DEF 14A | Proxy statementPeriod 2024-05-15 | 0001140361-24-017579 |
| 2024-03-1416:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001014739-24-000013 |
| 2024-02-2216:02 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001014739-24-000009 |
| 2024-02-2206:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-24-000007 |
| 2023-12-2916:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-130458 |
| 2023-12-1117:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-23-125031 |
| 2023-10-2516:02 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001014739-23-000042 |
| 2023-10-2507:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-23-000040 |
| 2023-07-2716:00 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001014739-23-000034 |
| 2023-07-2706:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001014739-23-000032 |
| 2023-06-2609:02 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-074575 |
| 2023-06-2107:00 ET | 8-K | 8.01 Other events | 0001104659-23-073117 |
| 2023-06-1217:02 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-165408 |
| 2023-05-1916:04 ET | 8-K | 5.07 Shareholder vote results | 0001014739-23-000022 |
| 2023-05-0417:00 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001014739-23-000019 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.